Journal of Modern OncologyJournal of Modern Oncology1815-14341815-1442LLC Obyedinennaya Redaktsiya26766Research ArticleKachestvo zhizni i simptomyu bol'nykh disseminirovannym gormonopozitivnym rakom molochnoy zhelezy v postmenopauze na fone primeneniya FazlodeksaNovikA A-IonovaT I-KalyadinaS A-15062009112192509042020Copyright © 2009, Consilium Medicum2009рак молочной железыантиэстрогеныфулвестрантФазлодекс[SCO. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncology 1996; 14 (3): 671–9.][Howell A, Robertson J.F., Abram P et al. Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double - blind, randomized trial. J Clin Oncol 2004; 22 (9): 1605–13.][Osborn C.K., Pippen J, Jones S.E. et al. Double - blined, randomized trial compairing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. J Clin Oncol 2002; 20 (16): 3386–95.][Robertson J.F., Osborne C.K., Howell A et al. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials. Cancer 2003; 98 (2): 229–38.][Hays R.D., Sherbourne C.D., Mazel R.M. User’s Manual for Medical Outcomes Study (MOS) Core measures of health - related quality of life. RAND Corporation, MR-162-RC (available at www.rand.org).][Ware J, Kosinski M, Keller S. SF-36 physical and mental summary scales: a user’s manual. Boston, MA: The Health Institute; 1994.][Новик А.А., Ионова Т.И., Гандек Б. и др. Показатели качества жизни населения Санкт - Петербурга. Пробл. стандарт. в здравоохр. 2001; 4: 22–31.][Новик А.А., Ионова Т.И. Исследование качества жизни в медицине: Учеб. пособие. Под ред. Ю.Л. Шевченко. М.: ГЭОТАР-МЕД, 2004.][Cleeland C.S., Mendoza T, Wang S et al. Assessing symptom distress in cancer patients. The M.D. Anderson Symptom Inventory. Cancer 2000; 89 (7): 1634–46.][Ivanova M.O., Ionova T.I., Kalyadina S.A. et al. Cancer - related symptom assessment in Russia: Validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Sympt Management 2005; 30 (5): 443–53.][Carol M. Funding Patient – Reported Outcomes in Cancer Clinical Trials. J Clin Oncol 2007; 10: 5100–5.][Новик А.А., Ионова Т.И., Кайнд П. Концепция исследования качества жизни в медицине. Спб.: Элби, 1999.][Рекомендации FDA для фармацевтической индустрии: использование оценок, сделанных пациентом, при внедрении новой медицинской продукции. Вестн. Межнац. центра кач. жизни. 2006; 7–8: 153–4]